Barclays trims Welltower price target to $246
Alpha Vantage · GuruFocus · · AI-summarised by FinFlash
Barclays analyst Richard Hightower kept an Equal-Weight rating on Welltower (WELL) while cutting the price target to $246.00 from $259.00. The healthcare REIT trades at $230.29, a 12.8% premium to its GF Value of $204.32, suggesting overvaluation. Its GF Score of 86/100 and notable insider buying signal underlying confidence. The lower target trims expected upside for investors holding the stock.
Understand the context
Published information may change. Summaries can contain errors; check the original source. Educational information only, not investment advice.